The Place of Cryopreserved Amniotic Membrane (CAM) in Treatment Protocols for Cornea-involved Ocular Surface Disease for the Optometrist.
Faculty Panelists: Paul Karpecki, MD, Doug Devries, OD, Art Epstein, OD, Damon Dierker, OD, and Ahmad Fahmy, OD
• This consensus guideline has been developed in order to reexamine the role of CAM in the management of cornea-involved ocular surface diseases, all of which present continued
• The group will re-examine the role of CAM in the management of persistent epithelial defect
(PED), corneal ulcer/infectious keratitis, recurrent corneal erosion (RCE), severe dry eye disease (DED), epithelial basement membrane dystrophy (EBMD), neurotrophic keratitis (NK), and the role of optimizing the ocular surface prior to refractive cataract surgery.
• These 5 renowned optometry experts in ocular surface disease management will highlight the existing consensus guideline and how it can be applied effectively by the Doctor of Optometry and/or through co-management with corneal specialists in their practice or community.